Dong Kee Jeong

Dong Kee Jeong


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
MGMeeta Gera
Meeta Gera
Neelesh SharmaNeelesh Sharma
Neelesh Sharma
MGMrinmoy Ghosh
Mrinmoy Ghosh
DHDo Luong Huynh
Do Luong Huynh
SLSung Jin Lee
Sung Jin Lee
DJDong Kee Jeong
Dong Kee Jeong
Nanoformulations of curcumin: an emerging paradigm for improved remedial application Nanoformulations of curcumin: an emerging paradigm for improved remedial application

30 November 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
HKHyebin Koh
Hyebin Koh
HPHyeri Park
Hyeri Park
NCNisansala Chandimali
Nisansala Chandimali
DHDo Luong Huynh
Do Luong Huynh
JZJiaojiao Zhang
Jiaojiao Zhang
DJDong Kee Jeong
Dong Kee Jeong
MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in cancer stem cells MicroRNA-128 suppresses Paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in Cancer Stem Cells

19 October 2018 in Cancer Gene Therapy
Verified
Journal Article
Open access
PDF file
NCNisansala Chandimali
Nisansala Chandimali
DHDo Luong Huynh
Do Luong Huynh
JZJiaojiao Zhang
Jiaojiao Zhang
JLJae Cheol Lee
Jae Cheol Lee
DYDae-Yeul Yu
Dae-Yeul Yu
Taeho KwonTaeho Kwon
Taeho Kwon
Previously, we demonstrated that Prx II is important for survival of the gefitinib-resistant A549 (A549/GR) cell line, an NSCLC cell line derived by repeated exposure to gefitinib. Therefore, in this study, we used A549/GR cells to investigate the role of Prx II in GR NSCLC stemness. Initially, to explore the stemness characteristics and investigate the association of Prx II with those stemness characteristics, we successfully isolated a stem cell-like population from A549/GR cells. A549/GR CD133+ cells possessed important cancer stemness characteristics, including the abilities to undergo metastasis, angiogenesis, self-renewal, and to express stemness genes and epithelial–mesenchymal transition (EMT) markers. However, those characteristics were abolished by knocking down Prx II expression. MicroRNA 122 (miR-122) targets Prx II in A549/GR cancer stem cells (CSCs), thereby inhibiting the stemness characteristics in vitro and in vivo. Next, we investigate whether miR-122 overexpression was associated with Prx II expression and Prx-II-induced stemness characteristics, we transfected miR-122 into A549/GR CSCs. MiR-122 inhibited A549/GR stemness by downregulating the Hedgehog, Notch, and Wnt/β-catenin pathways. Taken together, our data suggest that Prx II promotes A549/GR stemness, and that targeting Prx II and miR-122 is a potentially viable strategy for anti-cancer-stem cell therapy in GR NSCLCs.

20 September 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
JZJiaojiao Zhang
Jiaojiao Zhang
JJJin Oh Jo
Jin Oh Jo
DHDo Luong Huynh
Do Luong Huynh
MGMrinmoy Ghosh
Mrinmoy Ghosh
NKNameun Kim
Nameun Kim
DJDong Kee Jeong
Dong Kee Jeong
Lethality of inappropriate plasma exposure on chicken embryonic development Lethality of inappropriate plasma exposure on chicken embryonic development

14 February 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
Taeho KwonTaeho Kwon
Taeho Kwon
NCNisansala Chandimali
Nisansala Chandimali
DHDo Luong Huynh
Do Luong Huynh
JZJiaojiao Zhang
Jiaojiao Zhang
NKNameun Kim
Nameun Kim
DJDong Kee Jeong
Dong Kee Jeong
Chemotherapy is a standard treatment for non-small-cell lung cancer (NSCLC). However, the dose-limiting toxicity of drugs and the development of chemoresistance are major clinical challenges to successful management of NSCLC. Asian traditional medicine is gaining global attention as a non-toxic alternative to chemotherapy. BRM270 is an extract formulated from seven Asian medicinal plants that has been shown to inhibit tumor cell proliferation in diverse cancer types. We previously demonstrated that BRM270 suppresses tumorigenesis by negatively regulating nuclear factor-κB signaling in multidrug-resistant cancer stem cells (CSCs). In this study we report that the growth, migration, and invasion of normal human lung adenocarcinoma cells and their chemoresistant derivatives was inhibited by BRM270 treatment. Notably, BRM270 was found to modulate CSC self-renewal and tumor-initiating capacity via positive regulation of the miRNA-128. Thus, combination therapy with miRNA-128 and BRM270 may be an effective treatment strategy for chemoresistant NSCLC.

15 May 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JZJiaojiao Zhang
Jiaojiao Zhang
HDHuynh Luong Do
Huynh Luong Do
NCNisansala Chandimali
Nisansala Chandimali
SLSang Baek Lee
Sang Baek Lee
Young Sun MokYoung Sun Mok
Young Sun Mok
DJDong Kee Jeong
Dong Kee Jeong
The quality of avian semen is an important economic trait in poultry production. The present study examines thein vitroeffects of non-thermal dielectric barrier discharge plasma on chicken sperm to determine the plasma conditions that can produce the optimum sperm quality. Exposure to 11.7 kV of plasma for 20 s is found to produce maximum sperm motility by controlling the homeostasis of reactive oxygen species and boosting the release of adenosine triphosphate and respiratory enzyme activity in the mitochondria. However, prolonged exposure or further increase in plasma potential impairs the sperm quality in a time- and dose-dependent manner. Optimal plasma treatment of sperm results in upregulated mRNA and protein expression of antioxidant defense-related and energetic metabolism-related genes by increasing their demethylation levels. However, 27.6 kV of plasma exerts significant adverse effects. Thus, our findings indicate that appropriate plasma exposure conditions improve chicken sperm motility by regulating demethylation levels of genes involved in antioxidant defense and energetic metabolism.